Interventions that promote healthy lifestyles are critical for the prevention of Alzheimer’s disease and Alzheimer’s disease related dementias (AD/ADRD). However, knowledge of the best practices for implementing AD/ADRD prevention in healthcare settings remains limited.
Objective:
We aimed to qualitatively identify barriers and facilitators to implementing a clinical trial of a novel lifestyle intervention (My Healthy Brain) in our medical center for older patients with subjective cognitive decline who are at-risk for AD/ADRD.
Methods:
We conducted focus groups with 26 healthcare professionals (e.g., physicians, psychology, nursing) from 5 clinics that treat older patients (e.g., memory care, psychiatry). Our qualitative analysis integrated two implementation frameworks to systematically capture barriers and facilitators to AD/ADRD prevention (Consolidated Framework for Implementation Science Research) that impact implementation outcomes of acceptability, appropriateness, and feasibility (Proctor’s framework).
Results:
We found widespread support for an RCT of My Healthy Brain and AD/ADRD prevention. Participants identified barriers related to patients (stigma, technological skills), providers (dismissiveness of “worried well,” doubting capacity for behavior change), clinics (limited time and resources), and the larger healthcare system (underemphasis on prevention). Implementation strategies guided by Expert Recommendations for Implementing Change (ERIC) included: developing tailored materials, training staff, obtaining buy-in from leadership, addressing stigmatized language and practices, identifying “champions,” and integrating with workflows and resources.
Conclusions:
The results will inform our recruitment, enrollment, and retention procedures to implement the first randomized clinical trial of My Healthy Brain. Our study provides a blueprint for addressing multi-level barriers to the implementation of AD/ADRD prevention for older patients in medical settings.
GrandJH, CasparS and MacdonaldSW. Clinical features and multidisciplinary approaches to dementia care. J Multidiscip Healthc2011; 4: 125–147.
2.
CattaneoG, Bartrés-FazD, MorrisTP, et al. The Barcelona Brain Health Initiative: a cohort study to define and promote determinants of brain health. Front Aging Neurosci2018; 10: 321.
3.
GorelickPB, FurieKL, IadecolaC, et al. Defining optimal brain health in adults: a presidential advisory from the American Heart Association/American Stroke Association. Stroke2017; 48: e284–e303.
4.
GelfoF, MandolesiL, SerraL, et al. The neuroprotective effects of experience on cognitive functions: Evidence from animal studies on the neurobiological bases of brain reserve. Neuroscience2018; 370: 218–235.
JessenF, AmariglioRE, van BoxtelM, et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer’s disease. Alzheimers Dement2014; 10: 844–852.
7.
MolinuevoJL, RabinLA, AmariglioR, et al. Implementation of subjective cognitive decline criteria in research studies. Alzheimers Dement2017; 13: 296–311.
FonsecaJAS, DucksburyR, RoddaJ, et al. Factors that predict cognitive decline in patients with subjective cognitive impairment. Int Psychogeriatr2015; 27: 1671–1677.
10.
JessenF. Subjective and objective cognitive decline at the pre-dementia stage of Alzheimer’s disease. Eur Arch Psychiatry Clin Neurosci2014; 264(Suppl 1): S3–S7.
11.
VerlindenVJA, van der GeestJN, de BruijnRFAG, et al. Trajectories of decline in cognition and daily functioning in preclinical dementia. Alzheimers Dement2016; 12: 144–153.
12.
StudartA and NitriniR. Subjective cognitive decline: The first clinical manifestation of Alzheimer’s disease?Dement Neuropsychol2016; 10: 170–177.
13.
MitchellAJ, BeaumontH, FergusonD, et al. Risk of dementia and mild cognitive impairment in older people with subjective memory complaints: Meta-analysis. Acta Psychiatr Scand2014; 130: 439–451.
14.
SnitzBE, LopezOL, McDadeE, et al. Amyloid-beta imaging in older adults presenting to a memory clinic with subjective cognitive decline. J Alzheimers Dis2015; 48: S151–S159.
15.
CooperC, AguirreE, BarberJA, et al. APPLE-Tree (Active Prevention in People at risk of dementia: Lifestyle, bEhaviour change and Technology to REducE cognitive and functional decline) programme: Protocol. Int J Geriatr Psychiatry2020; 35: 811–819.
16.
LivingstonG, HuntleyJ, SommerladA, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet2020; 396: 413–446.
17.
BrookmeyerR, AbdallaN, KawasCH, et al. Forecasting the prevalence of preclinical and clinical Alzheimer’s disease in the United States. Alzheimers Dement2018; 14: 121–129.
18.
AndelR, CroweM, PedersenNL, et al. Physical exercise at midlife and risk of dementia three decades later: a population-based study of Swedish twins. J Gerontol A Biol Sci Med Sci2008; 63: 62–66.
19.
BaumgartM, SnyderHM, CarrilloMC, et al. Summary of the evidence on modifiable risk factors for cognitive decline and dementia: a population-based perspective. Alzheimers Dement2015; 11: 718–726.
20.
GedaYE, RobertsRO, KnopmanDS, et al. Physical exercise, aging, and mild cognitive impairment: a population-based study. Arch Neurol2010; 67: 80–86.
21.
HamerM and ChidaY. Physical activity and risk of neurodegenerative disease: a systematic review of prospective evidence. Psychol Med2009; 39: 3–11.
22.
XuW, TanL, WangH-F, et al. Meta-analysis of modifiable risk factors for Alzheimer’s disease. J Neurol Neurosurg Psychiatry2015; 86: 1299–1306.
23.
CooperC, LiR, LyketsosC, et al. Treatment for mild cognitive impairment: Systematic review. Br J Psychiatry2013; 203: 255–264.
TierneyMC, BlackSE, SzalaiJP, et al. Recognition memory and verbal fluency differentiate probable Alzheimer disease from subcortical ischemic vascular dementia. Arch Neurol2001; 58: 1654.
26.
HillNL, MogleJ, WionR, et al. Subjective cognitive impairment and affective symptoms: a systematic review. Gerontologist2016; 56: e109–e127.
27.
ZulloL, ClarkC, GholamM, et al. Factors associated with subjective cognitive decline in dementia-free older adults—A population-based study. Int J Geriatr Psychiatry2021; 36: 1188–1196.
28.
WhitmerRA, SidneyS, SelbyJ, et al. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology2005; 64: 277–281.
29.
LouridaI, HannonE, LittlejohnsTJ, et al. Association of lifestyle and genetic risk with incidence of dementia. JAMA2019; 322: 430–437.
30.
RabinJS, KleinH, KirnDR, et al. Associations of physical activity and β-amyloid with longitudinal cognition and neurodegeneration in clinically normal older adults. JAMA Neurol2019; 76: 1203–1210.
31.
AhlskogJE, GedaYE, Graff-RadfordNR, et al. Physical exercise as a preventive or disease-modifying treatment of dementia and brain aging. Mayo Clin Proc2011; 86: 876–884.
32.
MaceRA, GreenbergJ, StauderM, et al. Healthy Brain: a multimodal lifestyle program to promote brain health. Aging Ment Health2022; 26: 980–991.
33.
MaceRA, PopokPJ, HopkinsSW, et al. Adaptation and virtual feasibility pilot of a mindfulness-based lifestyle program targeting modifiable dementia risk factors in older adults. Aging Ment Health2023; 27: 695–707.
34.
MaceRA, HopkinsSW, ReynoldsGO, et al. My Healthy Brain: Rationale and case report of a virtual group lifestyle program targeting modifiable risk factors for dementia. J Clin Psychol Med Settings2022; 29: 818–830.
35.
YaffeK, BarnesDE, RosenbergD, et al. Systematic Multi-Domain Alzheimer’s Risk Reduction Trial (SMARRT): Study protocol. J Alzheimers Dis2019; 70: S207.
36.
NganduT, LehtisaloJ, SolomonA, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet2015; 385: 2255–2263.
37.
McMasterM, KimS, ClareL, et al. Lifestyle risk factors and cognitive outcomes from the multidomain dementia risk reduction randomized controlled trial, Body Brain Life for Cognitive Decline (BBL-CD). J Am Geriatr Soc2020; 68: 2629–2637.
38.
SPRINT MIND Investigators for the SPRINT Research Group, WilliamsonJD, PajewskiNM, et al. Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial. JAMA2019; 321: 553–561.
39.
Moll van CharanteEP, RichardE, EurelingsLS, et al. Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): a cluster-randomised controlled trial. Lancet2016; 388: 797–805.
40.
LamLC-W, ChanWC, LeungT, et al. Would older adults with mild cognitive impairment adhere to and benefit from a structured lifestyle activity intervention to enhance cognition? A cluster randomized controlled trial. PloS One2015; 10: e0118173.
41.
AndrieuS, GuyonnetS, ColeyN, et al. Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial. Lancet Neurol2017; 16: 377–389.
42.
ColeyN, NganduT, LehtisaloJ, et al. Adherence to multidomain interventions for dementia prevention: Data from the FINGER and MAPT trials. Alzheimers Dement2019; 15: 729–741.
43.
LudwigDS and Kabat-ZinnJ. Mindfulness in medicine. JAMA2008; 300: 1350–1352.
44.
GeigerPJ, BoggeroIA, BrakeCA, et al. Mindfulness-based interventions for older adults: a review of the effects on physical and emotional well-being. Mindfulness2016; 7: 296–307.
45.
DuttonG. The role of mindfulness in health behavior change. ACSMs Health Fit J2008; 12: 7–12.
46.
VictorsonD, KentorM, MaletichC, et al. Mindfulness meditation to promote wellness and manage chronic disease: a systematic review and meta-analysis of mindfulness-based randomized controlled trials relevant to lifestyle medicine. Am J Lifestyle Med2015; 9: 185–211.
47.
HölzelBK, CarmodyJ, VangelM, et al. Mindfulness practice leads to increases in regional brain gray matter density. Psychiatry Res2011; 191: 36–43.
48.
SevincG, HölzelBK, GreenbergJ, et al. Strengthened hippocampal circuits underlie enhanced retrieval of extinguished fear memories following mindfulness training. Biol Psychiatry2019; 86: 693–702.
49.
GotinkRA, MeijboomR, VernooijMW, et al. 8-week mindfulness based stress reduction induces brain changes similar to traditional long-term meditation practice – A systematic review. Brain Cogn2016; 108: 32–41.
50.
TangY-Y, HölzelBK and PosnerMI. The neuroscience of mindfulness meditation. Nat Rev Neurosci2015; 16: 213–225.
51.
CreswellJD and LindsayEK. How does mindfulness training affect health? A mindfulness stress buffering account. Curr Dir Psychol Sci2014; 23: 401–407.
52.
KilpatrickLA, SuyenobuBY, SmithSR, et al. Impact of mindfulness-based stress reduction training on intrinsic brain connectivity. Neuroimage2011; 56: 290–298.
53.
GardT, HölzelBK and LazarSW. The potential effects of meditation on age-related cognitive decline: a systematic review. Ann N Y Acad Sci2014; 1307: 89–103.
54.
SmartCM, SegalowitzSJ, MulliganBP, et al. Mindfulness training for older adults with subjective cognitive decline: Results from a pilot randomized controlled trial. J Alzheimers Dis2016; 52: 757–774.
55.
Russell-WilliamsJ, JaroudiW, PerichT, et al. Mindfulness and meditation: Treating cognitive impairment and reducing stress in dementia. Rev Neurosci2018; 29: 791–804.
56.
WetherellJL, HersheyT, HickmanS, et al. Mindfulness-based stress reduction for older adults with stress disorders and neurocognitive difficulties: a randomized controlled trial. J Clin Psychiatry2017; 78: e734–e743.
57.
LenzeEJ, HickmanS, HersheyT, et al. Mindfulness-based stress reduction for older adults with worry symptoms and co-occurring cognitive dysfunction. Int J Geriatr Psychiatry2014; 29: 991–1000.
58.
FriasCM de and WhyneE. Stress on health-related quality of life in older adults: The protective nature of mindfulness. Aging Ment Health2015; 19: 201–206.
59.
HerringA, BlomeM, AmbréeO, et al. Reduction of cerebral oxidative stress following environmental enrichment in mice with Alzheimer-like pathology: EH reduces oxidative stress in AD mice. Brain Pathol2010; 20: 166–175.
60.
BremnerJD. Does stress damage the brain?Biol Psychiatry1999; 45: 797–805.
61.
DeshmukhVD and DeshmukhSV. Stress-adaptation failure hypothesis of Alzheimer’s disease. Med Hypotheses1990; 32: 293–295.
62.
InnesKE,
SelfeTK. Meditation as a therapeutic intervention for adults at risk for Alzheimer’s disease – potential benefits and underlying mechanisms. Front Psychiatry2014; 5: 40.
63.
ParraDC, WetherellJL, Van ZandtA, et al. A qualitative study of older adults’ perspectives on initiating exercise and mindfulness practice. BMC Geriatr2019; 19: 354.
64.
ZeidanF, JohnsonSK, DiamondBJ, et al. Mindfulness meditation improves cognition: Evidence of brief mental training. Conscious Cogn2010; 19: 597–605.
65.
OnkenLS, CarrollKM, ShohamV, et al. Reenvisioning clinical science: Unifying the discipline to improve the public health. Clin Psychol Sci2014; 2: 22–34.
66.
AminzadehF, MolnarFJ, DalzielWB, et al. A review of barriers and enablers to diagnosis and management of persons with dementia in primary care. Can Geriatr J2012; 15: 85–94.
67.
StephanA, BieberA, HopperL, et al. Barriers and facilitators to the access to and use of formal dementia care: Findings of a focus group study with people with dementia, informal carers and health and social care professionals in eight European countries. BMC Geriatr2018; 18: 131.
68.
KulmalaJ, RosenbergA, NganduT, et al. Facilitators and barriers to implementing lifestyle intervention programme to prevent cognitive decline. Eur J Public Health2021; 31: 816–822.
69.
RosenbergA, ColeyN, SoulierA, et al. Experiences of dementia and attitude towards prevention: a qualitative study among older adults participating in a prevention trial. BMC Geriatr2020; 20: 99.
70.
DamschroderLJ, AronDC, KeithRE, et al. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci2009; 4: 50.
71.
ProctorE, SilmereH, RaghavanR, et al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health2011; 38: 65–76.
72.
BakhshaieJ, DoorleyJ, ReichmanM, et al. Optimizing the implementation of a multisite feasibility trial of a mind-body program in acute orthopedic trauma. Transl Behav Med2022; 12: 642–653.
73.
VranceanuA-M, BakhshaieJ, ReichmanM, et al. Understanding barriers and facilitators to implementation of psychosocial care within orthopedic trauma centers: a qualitative study with multidisciplinary stakeholders from geographically diverse settings. Implement Sci Commun2021; 2: 102.
74.
BowenDJ, KreuterM, SpringB, et al. How we design feasibility studies. Am J Prev Med2009; 36: 452–457.
75.
PalinkasLA, AaronsGA, HorwitzS, et al. Mixed method designs in implementation research. Adm Policy Ment Health2011; 38: 44–53.
76.
LeppinAL, MahoneyJE, StevensKR, et al. Situating dissemination and implementation sciences within and across the translational research spectrum. J Clin Transl Sci; 4: 152–158.
77.
VranceanuA-M, BakhshaieJ, ReichmanM, et al. A live video program to prevent chronic pain and disability in at-risk adults with acute orthopedic injuries (toolkit for optimal recovery): protocol for a multisite feasibility study. JMIR Res Protoc2021; 10: e28155.
78.
TotoP, YanesC, EnnisM, et al. Engaging stakeholders to implement an aging in place intervention through an area agency on aging. Innov Aging2020; 4: 873.
79.
DiMaria-GhaliliRA, SefcikJ, ClarkK, et al. Facilitators and barriers to engaging stakeholders in use-inspired aging research. Innov Aging2020; 4: 226.
80.
PeekSTM, WoutersEJM, LuijkxKG, et al. What it takes to successfully implement technology for aging in place: Focus groups with stakeholders. J Med Internet Res2016; 18: e98.
81.
GuestG, NameyE and McKennaK. How many focus groups are enough? Building an evidence base for nonprobability sample sizes. Field Methods2017; 29: 3–22.
82.
MansfieldE, NobleN, Sanson-FisherR, et al. Primary care physicians’ perceived barriers to optimal dementia care: a systematic review. Gerontologist2019; 59: e697–e708.
83.
Van AlphenHJM, HortobágyiT and Van HeuvelenMJG. Barriers, motivators, and facilitators of physical activity in dementia patients: a systematic review. Arch Gerontol Geriatr2016; 66: 109–118.
84.
HollisV, OpenshawS and GobleR. Conducting focus groups: purpose and practicalities. Br J Occup Ther2002; 65: 2–8.
85.
GaleRC, WuJ, ErhardtT, et al. Comparison of rapid vs in-depth qualitative analytic methods from a process evaluation of academic detailing in the Veterans Health Administration. Implement Sci2019; 14: 11.
86.
TaylorB, HenshallC, KenyonS, et al. Can rapid approaches to qualitative analysis deliver timely, valid findings to clinical leaders? A mixed methods study comparing rapid and thematic analysis. BMJ Open2018; 8: e019993.
87.
HamiltonAB and FinleyEP. Qualitative methods in implementation research: an introduction. Psychiatry Res2019; 280: 112516.
88.
GaleNK, HeathG, CameronE, et al. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol2013; 13: 117.
89.
RitchieJ and SpencerL. Qualitative data analysis for applied policy research. In: BrymanA, BurgessRG (eds) Analyzing qualitative data. Abingdon, UK: Taylor & Francis, pp. 173–194.
90.
SocioCultural Research Consultants, LLC. Dedoose Version 9.2.007,
cloud application for managing, analyzing, and presenting qualitative and mixed method research data, www.dedoose.com (2024).
91.
WaltzTJ, PowellBJ, FernándezME, et al. Choosing implementation strategies to address contextual barriers: Diversity in recommendations and future directions. Implement Sci2019; 14: 42.
92.
KenningC, Daker-WhiteG, BlakemoreA, et al. Barriers and facilitators in accessing dementia care by ethnic minority groups: a meta-synthesis of qualitative studies. BMC Psychiatry2017; 17: 316.
93.
MaceRA, GatesMV, BullardB, et al. Development of a novel mind-body activity and pain management program for older adults with cognitive decline. Gerontologist2021; 61: 449–459.
94.
MacLeodS, MusichS, GulyasS, et al. The impact of inadequate health literacy on patient satisfaction, healthcare utilization, and expenditures among older adults. Geriatr Nurs2017; 38: 334–341.
95.
FlodgrenG, ParmelliE, DoumitG, et al. Local opinion leaders: Effects on professional practice and health care outcomes. Cochrane Database Syst Rev2011; CD000125.
96.
ColeyN, Coniasse-BrioudeD, IgierV, et al. Disparities in the participation and adherence of older adults in lifestyle-based multidomain dementia prevention and the motivational role of perceived disease risk and intervention benefits: an observational ancillary study to a randomised controlled trial. Alzheimers Res Ther2021; 13: 157.
97.
KorpP. Problems of the healthy lifestyle discourse: problems of the healthy lifestyle discourse. Sociol Compass2010; 4: 800–810.
98.
MaceRA, MattosMK, VranceanuA-M. Older adults can use technology: Why healthcare professionals must overcome ageism in digital health. Transl Behav Med2022; ibac070.
99.
WeuveJ, BarnesLL, Mendes de LeonCF, et al. Cognitive aging in Black and White Americans: Cognition, cognitive decline, and incidence of Alzheimer disease dementia. Epidemiology2018; 29: 151–159.
100.
SawyerK, Sachs-EricssonN, PreacherKJ, et al. Racial differences in the influence of the APOE epsilon 4 allele on cognitive decline in a sample of community-dwelling older adults. Gerontology2009; 55: 32–40.
101.
Moody-AyersSY, MehtaKM, LindquistK, et al. Black-White disparities in functional decline in older persons: The role of cognitive function. J Gerontol A Biol Sci Med Sci2005; 60: 933–939.
102.
YaffeK, LindquistK, PenninxBW, et al. Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology2003; 61: 76–80.
103.
BarnesLL. Biomarkers for Alzheimer dementia in diverse racial and ethnic minorities—a public health priority. JAMA Neurol2019; 76: 251.
104.
BarnesLL and BennettDA. Alzheimer’s disease in African Americans: Risk factors and challenges for the future. Health Aff Proj Hope2014; 33: 580–586.
105.
InouyeSK, BogardusJr.ST, BakerDI, et al. The Hospital Elder Life Program: a model of care to prevent cognitive and functional decline in older hospitalized patients. Hospital Elder Life Program. J Am Geriatr Soc2000; 48: 1697–1706.
106.
KaongaNN and MorganJ. Common themes and emerging trends for the use of technology to support mental health and psychosocial well-being in limited resource settings: a review of the literature. Psychiatry Res2019; 281: 112594.
107.
AltomareD, MolinuevoJL, RitchieC, et al. Brain Health Services: Organization, structure, and challenges for implementation. A user manual for Brain Health Services-part 1 of 6. Alzheimers Res Ther2021; 13: 168.
